Mechanical signaling in reproductive tissues: Mechanisms and importance

Reproductive Sciences

Volumn 21, Issue 9, 2014, Pages 1093-1107

  Jorge, Soledad ^a,b   Chang, Sydney ^a,c   Barzilai, Joshua J ^d   Leppert, Phyllis ^c   Segars, James H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

cervical insufficiency; endometriosis; extracellular matrix; fibroids; mechanotransduction; ROCK Rho kinase

Indexed keywords

ADAPTATION; BREAST CANCER; ENDOMETRIOSIS; ENDOMETRIUM; EXTRACELLULAR MATRIX; FEMALE; FEMALE GENITAL SYSTEM; HUMAN; INVOLUTION; MAMMARY GLAND; MECHANOTRANSDUCTION; MENOPAUSE; NIDATION; NONHUMAN; OSMOTIC STRESS; OVARY; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; OVULATION; PLASTICITY; PREGNANCY; PREMATURE LABOR; PUBERTY; REVIEW; UTERINE CERVIX; UTERINE CERVIX INCOMPETENCE; UTERUS; UTERUS LEIOMYOMATA; UTERUS TUMOR; ANIMAL; BREAST; PHYSIOLOGY; REPRODUCTION; SIGNAL TRANSDUCTION;

ANIMALS; BREAST; CERVIX UTERI; ENDOMETRIUM; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MECHANOTRANSDUCTION, CELLULAR; OVARY; PREGNANCY; REPRODUCTION; SIGNAL TRANSDUCTION;

EID: 84907217233     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719114542023     Document Type: Review

References (140)

1. Bissel MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression? J Theor Biol. 1982;99(1):31-68.
2. Ingber DE. Integrins as mechanochemical transducers. Curr Opin Cell Biol. 1991;3(5):841-848.
3. Ingber DE. Cellular mechanotransduction: putting all the pieces together again. FASEB J. 2006;20(7):811-827.
4. Kuo JC. Mechanotransduction at focal adhesions: integrating cytoskeletal mechanics in migrating cells. J Cell Mol Med. 2013;17(6):704-712.
5. Sukharev S, Corey D. Mechanosensitive channels: multiplicity of families and gating paradigms. Sci STKE. 2004;2004(219): re4.
6. Sawada Y, Tamada M, Dubin-Thaler BJ, et al. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell. 2006;127(5):1015-1026.
7. Putnam AJ, Schultz K, Mooney DJ. Control of microtubule assembly by the extracellular matrix. Am J Physiol. 2001; 280(3):C556-C564.
8. Agha R, Ogawa R, Pietramaggiori G, Orgill DP. A review of the role of mechanical forces in cutaneous wound healing. J Surg Res. 2011;171(2):700-708.
9. Tamada M, Sheetz MP, Sawada Y. Activation of a signaling cascade by cytoskeletal stretch. Dev Cell. 2004;7(5):709-718.
10. Jaalouk DE, Lammerding J. Mechanotransduction gone awry. Nat Rev Mol Cell Biol. 2009;10(1):63-73.
11. Ghosh K, Ingber DE. Micromechanical control of cell and tissue development: implications for tissue engineering. Adv Drug Deliv Rev. 2007;10(13):1306-1318.
12. Boudreau N, Bissell MJ. Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr Poin Cell Biol. 1998;10(5):640-646.
13. Hubmacher D, Apte SS. The biology of the extracellular matrix: novel insights. Curr Opin Rheumatol. 2013;25(1):65-70.
14. Mammoto A, Mommoto T, Ingber DE. Rho signaling and mechanical control of vascular development. Curr Opin Hematol. 2008;15(3):228-234.
15. Liu H, Tang Liling. Mechano-regulation of alternative splicing. Curr Genomics. 2013;14(1):49-55.
16. Amano M, Chihara K, Kimura K, et al. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science. 1997;275(5304):1308-1311.
17. Chen G, Lv Y, Guo P, et al. Matrix mechanics and fluid shear stress control stem cells fate in three dimensional microenvironment. Curr Stem Cell Res Ther. 2013;8(4):313-323.
18. Raya-Rivera AM, Esquiliano D, Fierro-Pastrana R, et al. Tissue-engineered autologous vaginal organs in patients: a pilot cohort study [published online 11 April 2014]. Lancet. 2014.
19. Brown BN, Badylak SF. Extracellular matrix as an inductive scaffold for functional tissue reconstruction. Transl Res. 2014;163(4): 268-285.
20. Monga M, Sanborn BM. Biology and physiology of the reproductive tract and control of myometrial contraction. In: Creasy R, Resnik R, Iams J, eds. Maternal-Fetal Medicine: Principles and Practice. Philadelphia, PA: Saunders; 2004; 68-78.
21. Martin L, Finn CA, Trinder G. Hypertrophy and hyperplasia in the mouse uterus after oestrogen treatment: an autoradiographic study. J Endocrinol. 1973;56(1):133-144.
22. Koseki Y, Fujimoto GI. Progesterone effects contrasted with 17beta-estradiol on DNA synthesis and epithelial nuclear proliferation in the castrate rabbit uterus. Biol Reprod. 1974;10(5): 596-604.
23. Csapo A, Erdos T, De Mattos CR, Gramss E, Moscowitz C. Stretch-induced uterine growth, protein synthesis and function. Nature. 1965;207(5004):1378-1379.
24. Douglas AJ, Clarke EW, Goldspink DF. Influence of mechanical stretch on growth and protein turnover of rat uterus. Am J Physiol. 1988;254:E543-E548.
25. Cullen BM, Harkness RD. Collagen formation and changes in cell population in the rat's uterus after distension with wax. Q J Exp Physiol Cogn Med Sci. 1968;53(1):33-42.
26. Goldspink DF, Douglas AJ. Protein turnover in gravid and non-gravid horns of uterus in pregnant rats. Am J Physiol. 1988; 254(5 pt 1):E549-E554.
27. Shynlova O, Kwong R, Lye SJ. Mechanical stretch regulates hypertrophic phenotype of the myometrium during pregnancy. Reproduction. 2010;139(1):247-253.
28. Shynlova O, Oldenhof A, Dorogin A, et al. Myometrial apoptosis: activation of the caspase cascade in the pregnant rat myometrium at midgestation. Biol Reprod. 2006;74(5):839-849.
29. Shynlova O, Lee Y, Srikhajon K, Lye SJ. Physiologic uterine inflammation and labor onset: integratin of endocrine and mechanical signals. Reprod Sci. 2012;20(2):154-167.
30. Salameh A, Dhein S. Effects of mechanical forces and stretch on intracellular gap junction coupling. Biochem Biophys Acta. 2013; 1828(1):147-156.
31. Dalrymple A, Mahn K, Poston L, Songu-Mize E, Tribe RM. Mechanical stretch regulates TRPC expression and calcium entry in human myometrial smooth muscle cells. Mol Hum Reprod. 2007;13(3):171-179.
32. Niiro N, Nishimura J, Sakihara C, Nakano H, Kanaide H. Up-regulation of rho A and rho-kinase mRNAs in the rat myometrium during pregnancy. Biochem Biophys Res Commun. 1997; 230(2):356-359.
33. Moran CJ, Friel AM, Smith TJ, Cairns M, Morrison JJ. Expression and modulation of Rho kinase in human pregnant myometrium. Mol Hum Reprod. 2002;8(2):196-200.
34. Friel AM, Curley M, Ravikumar N, Smith TJ, Morrison JJ. Rho A/Rho kinase mRNA and protein levels in human myometrium during pregnancy and labor. J Soc Gynecol Investig. 2005; 12(1):20-27.
35. Li Y, Gallant C, Malek S, Morgan KG. Focal adhesion signaling is required for myometrial ERK activation and contractile phenotype switch before labor. J Cell Biochem. 2007;100(1): 129-140.
36. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med. 1998;339(5):313-320.
37. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348(24):2379-2385.
38. Lim AC, Schuit E, Bloemenkamp K, et al. 17alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial. Obstet Gynecol. 2011;118(3):513-520.
39. Sanborn BM. Hormones and calcium: mechanisms controlling uterine smooth muscle contractile activity. The Litchfield Lecture. Exp Physiol. 2001;86(2):223-237.
40. Berto AG, Oba SM, Michelacci YM, Sampaio LO. Galactosaminoglycans from normal myometrium and leiomyoma. Braz J Med Biol Res. 2001;34:633-637.
41. Malik M, Norian J, McCarthy-Keith D, Britten J, Catherino WH. Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women. Semin Reprod Med. 2010; 28(3):169-179.
42. Leppert PC, Baginski T, Prupas C, Catherino WH, Pletcher S, Segars JH. Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil Steril. 2004; 82(suppl 3):1182-117.
43. Sampaio LO, Dietrich CP, Filho OG. Changes in sulfated muco-polysaccharide composition of mammalian tissues during growth and in cancer tissues. Biochim Biophys Acta. 1977;498(1): 123-131.
44. Berto AG, Sampaio LO, Franco CR, Cesar RM Jr, Michelacci YM. A comparative analysis of structure and spatial distribution of decorin in human leiomyoma and normal myometrium. Biochim Biophys Acta. 2003;1619(1):98-112.
45. Rogers R, Norian J, Malik M, et al. Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol. 2008; 198(4):474. e1-e11.
46. Norian JM, Owen CM, Taboas J, et al. Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma. Matrix Biol. 2012;31(1):57-65.
47. Ingber DE. Can cancer be reversed by engineering the tumor microenvironment? Semin Cancer Biol. 2008;18(5):356-364.
48. Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer. 2009;9(2):108-122.
49. Paszek MJ, Weaver VM. The tension mounts: mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia. 2004;9(4):325-342.
50. Paszek MJ, Zahir N, Johnson KR, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8(3):241-254.
51. Crabtree JS, Jelinsky SA, Harris HA, et al. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway. Cancer Res. 2009; 69(15):6171-6178.
52. Karra L, Shushan A, Ben-Meir A, et al. Changes related to phosphatidylinositol 3-kinase/Akt signaling in leiomyomas: possible involvement of glycogen synthase kinase 3alpha and cyclin D2 in the pathophysiology. Fertil Steril. 2010;93(8): 2646-2651.
53. Varghese BV, Koohestani F, McWilliams M, et al. Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway. Proc Natl Acad Sci USA. 2013;110(6): 2187-2192.
54. Zanchi NE, Lancha AH Jr. Mechanical stimuli of skeletal muscle: implications on mTOR/p70s6k and protein synthesis. Eur J Appl Physiol. 2008;102(3):253-263.
55. Aleem FA, Predanic M. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography. Gynecol Endocrinol. 1995;9(3):253-258.
56. Okuda S, Oshio K, Shinmoto H, et al. Semiquantitative assessment of MR imaging in prediction of efficacy of gonadotropinreleasing hormone agonist for volume reduction of uterine leiomyoma: initial experience. Radiology. 2008;248(3):917-924.
57. McCarthy-Keith DM, Malik M, Britten J, Segars J, Catherino WH. Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells. Fertil Steril. 2011;95(7):2383-2387.
58. West CP, Lumsden MA, Lawson S, Williamson J, Baird DT. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil Steril. 1987;48(1):45-51.
59. Britten JL, Malik M, Levy G, Mendoza M, Catherino WH. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production. Fertil Steril. 2012; 98(5):1299-1307.
60. Parker JD, Malik M, Catherino WH. Human myometrium and leiomyomas express gonadotropin-releasing hormone 2 and gonadotropin-releasing hormone 2 receptor. Fertil Steril. 2007; 88(1):39-46.
61. Leppert PC. Anatomy and physiology of cervical ripening. Clin Obstet Gynecol. 1995;38(2):267-279.
62. Myers KM, Socrate S, Paskaleva A, House M. A study of the anisotropy and tension/compression behavior of human cervical tissue. J Biomech Eng. 2010;132(2):021003.
63. Liu X, Wu H, Byrne M, Krane S, Jaenisch R. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci USA. 1997; 94(5):1852-1856.
64. Aspden RM. Collagen organisation in the cervix and its relation to mechanical function. Coll Relat Res. 1988;8(2):103-112.
65. Weiss S, Jaermann T, Schmid P, et al. Three-dimensional fiber architecture of the nonpregnant human uterus determined ex vivo using magnetic resonance diffusion tensor imaging. Anat Rec A Discov Mol Cell Evol Biol. 2006;288(1):84-90.
66. Read CP, Word RA, Ruscheinsky MA, Timmons BC, Mahendroo MS. Cervical remodeling during pregnancy and parturition: molecular characterization of the softening phase in mice. Reproduction. 2007;134(2):327-340.
67. Word RA, Li XH, Hnat M, Carrick K. Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts. Semin Reprod Med. 2007;25(1):69-79.
68. House M, Kaplan DL, Socrate S. Relationships between mechanical properties and extracellular matrix constituents of the cervical stroma during pregnancy. Semin Perinatol. 2009;33(5):300-307.
69. Drzewiecki G, Tozzi C, Yu SY, Leppert PC. A dual mechanism of biochemical change in rat cervix in gestation and postpartum: applied vascular mechanics. Cardiovasc Eng. 2005;5(4):187-193.
70. Timmons B, Akins M, Mahendroo M. Cervical remodeling during pregnancy and parturition. Trends Endocrinol Metab. 2010;21(6): 353-361.
71. Leppert PC, Woessner JF. The Extracellular Matrix of the Uterus, Cervix and Fetal Membranes: Synthesis, Degradation and Hormonal Regulation. Ithaca, NY: Perinatology Press; 1991:68-76.
72. Leppert P. Cervical softening, effacement and dilatation: a complex biochemical cascade. J Maternal Fetal Med. 1992;1(4): 213-223.
73. Akgul Y, Holt R, Mummert M, Word A, Mahendroo M. Dynamic changes in cervical glycosaminoglycan composition during normal pregnancy and preterm birth. Endocrinology. 2012;153(7): 3493-503.
74. Ruscheinsky M, De la Motte C, Mahendroo M. Hyaluronan and its binding proteins during cervical ripening and parturition: dynamic changes in size, distribution and temporal sequence. Matrix Biol. 2008;27(5):487-497.
75. Takemura M, Itoh H, Sagawa N, et al. Cyclic mechanical stretch augments hyaluronan production in cultured human uterine cervical fibroblast cells. Mol Hum Reprod. 2005;11(9):659-665.
76. Gonzalez JM, Xu H, Chai J, Ofori E, Elovitz MA. Preterm and term cervical ripening in CD1 Mice (Mus musculus): similar or divergent molecular mechanisms? Biol Reprod. 2009;81(6): 1226-1232.
77. Timmons BC, Mahendroo MS. Timing of neutrophil activation and expression of proinflammatory markers do not support a role for neutrophils in cervical ripening in the mouse. Biol Reprod. 2006;74(2):236-245.
78. Timmons BC, Fairhurst AM, Mahendroo MS. Temporal changes in myeloid cells in the cervix during pregnancy and parturition. J Immunol. 2009;182(5):2700-2707.
79. Hirsch E, Muhle R. Intrauterine bacterial inoculation induces labor in the mouse by mechanisms other than progesterone withdrawal. Biol Reprod. 2002;67(4):1337-1341.
80. Anum EA, Hill LD, Pandya A, Strauss JF III. Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity. Placenta. 2009;30(3):207-215.
81. Leppert PC, Yu SY, Keller S, Cerreta J, Mandl I. Decreased elastic fibers and desmosine content in incompetent cervix. Am J Obstet Gynecol. 1987;157(5):1134-1139.
82. Finn CA. Endocrine control of endometrial sensitivity during the induction of the decidual cell reaction in the mouse. J Endocrinol. 1966;36(3):239-248.
83. Lejeune B, Lecocq R, Lamy F, Leroy F. Changes in the pattern of endometrial protein synthesis during decidualization in the rat. J Reprod Fertil. 1982;66(2):519-523.
84. Almog B, Shalom-Paz E, Dufort D, Tulandi T. Promoting implantation by local injury to the endometrium. Fertil Steril. 2010; 94(6):2026-2029.
85. Fronius M, Clauss WG. Mechano-sensitivity of ENaC: may the (shear) force be with you. Pflugers Arch. 2008;455(5):775-785.
86. Chan LN, Tsang LL, Rowlands DK, et al. Distribution and regulation of ENaC subunit and CFTR mRNA expression in murine female reproductive tract. J Membr Biol. 2002;185(2):165-176.
87. Kleyman TR, Carattino MD, Hughey RP. ENaC at the cutting edge: regulation of epithelial sodium channels by proteases. J Biol Chem. 2009;284(31):20447-20451.
88. Vallet V, Chraibi A, Gaeggeler HP, Horisberger JD, Rossier BC. An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature. 1997;389(6651):607-610.
89. Ruan YC, Guo JH, Liu X, et al. Activation of the epithelial Na(+)channel triggers prostaglandin E(2) release and production required for embryo implantation. Nat Med. 2012;18(7): 1112-1117.
90. Hama K, Aoki J, Inoue A, et al. Embryo spacing and implantation timing are differentially regulated by LPA3-mediated lysophosphatidic acid signaling in mice. Biol Reprod. 2007;77(6): 954-959.
91. Hama K, Aoki J, Bandoh K, et al. Lysophosphatidic receptor, LPA3, is positively and negatively regulated by progesterone and estrogen in the mouse uterus. Life Sci. 2006;79(18):1736-1740.
92. Ye X, Hama K, Contos JJ, et al. LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature. 2005; 435(7038):104-108.
93. Dixon RE, Hennig GW, Baker SA, et al. Electrical slow waves in the mouse oviduct are dependent epon a calcium activated chloride conductance encoded by Temem16a. Biol Reprod. 2012; 86(1):1-7.
94. Harada M, Osuga Y, Hirota Y, et al. Mechanical stretch stimulates interleukin-8 production in endometrial stromal cells: possible implications in endometrium-related events. J Clin Enocrinol Metab. 2005;90(2):1144-1148.
95. Ryan IP, Tseng JF, Schriock ED, Khorram O, Landers DV, Taylor RN. Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril. 1995; 63(4):929-932.
96. Calhaz-Jorge C, Costa AP, Santos MC, Palma-Carlos ML. Peritoneal fluid concentrations of interleukin-8 in patients with endometriosis depend on the severity of the disorder and are higher in the luteal phase. Hum Reprod. 2003;18(3):593-597.
97. Arici A. Local cytokines in endometrial tissue: the role of interleukin-8 in the pathogenesis of endometriosis. Ann N Y Acad Sci. 2002;955:101-109; discussion 18, 396-406.
98. Ulukus M, Ulukus EC, Seval Y, Zheng W, Arici A. Expression of interleukin-8 receptors in endometriosis. Hum Reprod. 2005; 20(3):794-801.
99. Hornick JE, Duncan FE, Shea LD, Woodruff TK. Isolated primate primordial follicles require a rigid physical environment to survive and grow in vitro. Hum Reprod. 2012;27(6):1801-1810.
100. Woodruff TK, Shea LD. A new hypothesis regarding ovarian follicle development: ovarian rigidity as a regulator of selection and health. J Assist Reprod Genet. 2011;28(1):3-6.
101. Tingen C, Kim A, Woodruff TK. The primordial pool of follicles and nest breakdown in mammalian ovaries. Mol Hum Reprod. 2009;15(12):795-803.
102. John GB, Gallardo TD, Shirley LJ, Castrillon DH. Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth. Dev Biol. 2008;321(1):197-204.
103. Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science. 2003;301(5630):215-218.
104. Xu M, Kreeger PK, Shea LD, Woodruff TK. Tissue-engineered follicles produce live, fertile offspring. Tissue Eng. 2006;12(10): 2739-2746.
105. West ER, Xu M, Woodruff TK, Shea LD. Physical properties of alginate hydrogels and their effects on in vitro follicle development. Biomaterials. 2007;28(30):4439-4448.
106. Shikanov A, Xu M, Woodruff TK, Shea LD. Interpenetrating fibrin-alginate matrices for in vitro ovarian follicle development. Biomaterials. 2009;30(29):5476-5485.
107. LaPolt PS, Lu JK. Effects of aging on luteinizing hormone secretion, ovulation, and ovarian tissue-type plasminogen activator expression. Exp Biol Med. 2001;226(2):127-132.
108. LaPolt PS, Yamoto M, Veljkovic M, et al. Basic fibroblast growth factor induction of granulosa cell tissue-type plasminogen activator expression and oocyte maturation: potential role as a paracrine ovarian hormone. Endocrinology. 1990;127(5): 2357-2363.
109. Xu M, West E, Shea LD, Woodruff TK. Identification of a stage-specific permissive in vitro culture environment for follicle growth and oocyte development. Biol Reprod. 2006;75(6): 916-923.
110. Kawamura K, Cheng Y, Suzuki N, et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA. 2013;110(43):17474-17479.
111. Matousek M, Carati C, Gannon B, Brannstrom M. Novel method for intrafollicular pressure measurements in the rat ovary: increased intrafollicular pressure after hCG stimulation. Reproduction. 2001;121(2):307-314.
112. Curry TE Jr, Smith MF. Impact of extracellular matrix remodeling on ovulation and the folliculo-luteal transition. Semin Reprod Med. 2006;24(4):228-241.
113. Espey LLLH. Ovulation. In: Knobil ENJ, ed. The Physiology of Reproduction. 2nd ed. New York: Raven Press; 1994: 725-780.
114. Davis BJ, Lennard DE, Lee CA, et al. Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1beta. Endocrinology. 1999;140(6): 2685-2695.
115. Murdoch WJ, Gottsch ML. Proteolytic mechanisms in the ovulatory folliculo-luteal transformation. Connect Tissue Res. 2003;44(1):50-57.
116. P T. Muscular apparatus of the ovarian follicle. In: Familiari G, Makabe S, Motta PM, eds. Ultrastructure of the Ovary. Amsterdam: Kluwer Academic Publishers; 1991:129-141.
117. Walles B, Groschel-Stewart U, Kannisto P, Owman C, Sjoberg NO, Unsicker K. Immunocytochemical demonstration of contractile cells in the human ovarian follicle. Experientia. 1990; 46(7):682-683.
118. Ko C, Gieske MC, Al-Alem L, et al. Endothelin-2 in ovarian follicle rupture. Endocrinology. 2006;147(4):1770-1779.
119. Bridges PJ, Jo M, Al Alem L, et al. Production and binding of endothelin-2 (EDN2) in the rat ovary: endothelin receptor subtype A (EDNRA)-mediated contraction. Reprod Fertil Dev. 2010;22(5):780-787.
120. Hughesdon PE. Morphology and morphogenesis of the Stein- Leventhal ovary and of so-called ''hyperthecosis''. Obstet Gynecol Surv. 1982;37(2):59-77.
121. D'Ascenzo S, Giusti I, Millimaggi D, et al. Intrafollicular expression of matrix metalloproteinases and their inhibitors in normally ovulating women compared with patients undergoing in vitro fertilization treatment. Eur J Endocrinol. 2004;151(1): 87-91.
122. Tarkun I, Canturk Z, Arslan BC, Turemen E, Tarkun P. The plasminogen activator system in young and lean women with polycystic ovary syndrome. Endocr J. 2004;51(5):467-472.
123. Schere-Levy C, Buggiano V, Quaglino A, et al. Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. Exp Cell Res. 2003;282(1):35-47.
124. Kritikou EA, Sharkey A, Abell K, et al. A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development. 2003;130(15): 3459-3468.
125. Marti A, Feng Z, Altermatt HJ, Jaggi R. Milk accumulation triggers apoptosis of mammary epithelial cells. Eur J Cell Biol. 1997;73(2):158-165.
126. Quaglino A, Salierno M, Pellegrotti J, Rubinstein N, Kordon EC. Mechanical strain induces involution-associated events in mammary epithelial cells. BMC Cell Biol. 2009;10:55.
127. Oldenhof AD, Shynlova OP, Liu M, Langille BL, Lye SJ. Mitogen-activated protein kinases mediate stretch-induced c-fos mRNA expression in myometrial smooth muscle cells. Am J Physiol Cell Physiol. 2002;283(5): C1530-C1539.
128. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995;270(26):16483-16486.
129. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. 2003;3(11):859-868.
130. Jenab S, Morris PL. Testicular leukemia inhibitory factor (LIF) and LIF receptor mediate phosphorylation of signal transducers and activators of transcription (STAT)-3 and STAT-1 and induce c-fos transcription and activator protein-1 activation in rat Sertoli but not germ cells. Endocrinology. 1998;139(4): 1883-1890.
131. Abell K, Bilancio A, Clarkson RW, et al. Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition. Nat Cell Biol. 2005;7(4):392-398.
132. Schwertfeger KL, Richert MM, Anderson SM. Mammary gland involution is delayed by activated Akt in transgenic mice. Mol Endocrinol. 2001;15(6):867-881.
133. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumorstromal interface facilitates local invasion. BMC Med. 2006; 4(1):38.
134. Levental KR, Yu H, Kass L, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906.
135. Wozniak MA, Desai R, Solski PA, Der CJ, Keely PJ. ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J Cell Biol. 2003;163(3):583-595.
136. Bignon M, Pichol-Thievend C, Hardouin J, et al. Lysyl oxidaselike protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane. Blood. 2011;118(14):3979-3989.
137. Le QT, Harris J, Magliocco AM, et al. Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: radiation therapy oncology group trial 90-03. J Clin Oncol. 2009;27(26):4281-4286.
138. Fu XD, Goglia L, Sanchez AM, et al. Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase. Endocr Relat Cancer. 2010;17(2):431-443.
139. Daniel AR, Knutson TP, Lange CA. Signaling inputs to progesterone receptor gene regulation and promoter selectivity. Mol Cell Endocrinol. 2009;308(1-2):47-52.
140. Kino T, Segars JH, Chrousos GP. The quanine nucleotide exchange for BRX: a link between osmotic stress, inflamatory and organ physiology and pathophysiology. Expert Rev Endocrinol Metab. 2010;5(4):603-608.